Home › NDC Lookup › RxCUI directory › RxCUI 1797833

Ipratropium bromide 0.021 MG/ACTUAT Metered Dose Nasal Spray — RxCUI 1797833

RxNorm drug concept · Semantic clinical drug
RxCUI 1797833 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1797833
Official nameIpratropium bromide 0.021 MG/ACTUAT Metered Dose Nasal Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asipratropium bromide 21 MCG/ACTUAT Metered Dose Nasal Spray; ipratropium Br 21 MCG/ACTUAT (0.03 % ) Metered Dose Nasal Spray
FDA products mapped9
Package NDCs mapped9
Reported Medicaid activity (SDUD)123,336 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ipratropium Nasal Spray: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Unfortunately, no. Ipratropium nasal spray is designed specifically to reduce a runny nose — it blocks the glands that produce nasal fluid. It doesn't do anything for congestion or...
  • Will this spray help with my stuffiness and sneezing too?
  • You can expect to notice a reduction in nasal dripping within about an hour of your first dose — that's what clinical studies showed. Use it consistently as directed throughout the...
  • That depends on why you're using it. For a cold, safety and effectiveness have only been established for up to four days. For seasonal allergies, it's been studied for up to three...
📖 Read our full Ipratropium Nasal Spray guide →

🕸️ Concept Web — How Ipratropium bromide 0.021 MG/ACTUAT Metered Dose... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ipratropium bromide 0.021 MG/ACTUAT Metered Dose Nasal Spray RxCUI 1797833

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Ipratropium 7213
    • Ipratropium bromide 203212
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ipratropium Metered Dose Nasal Spray 1797832
    • Ipratropium bromide Metered Dose Nasal Spray 2647917
    • Ipratropium Inhalant Product 1158614
    • Ipratropium Nasal Product 1158615
    • Ipratropium bromide Inhalant Product 2663525
    • Ipratropium bromide Nasal Product 2660664
    • Metered Dose Nasal Spray 1797831
    • Inhalant Product 1151123
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Ipratropium bromide 0.021 MG/ACTUAT 836291

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ipratropium bromide 0.021 MG/ACTUAT SCDC · 836291
  • Ipratropium Metered Dose Nasal Spray SCDF · 1797832
  • Ipratropium bromide Metered Dose Nasal Spray SCDFP · 2647917
  • Ipratropium Inhalant Product SCDG · 1158614
  • Ipratropium Nasal Product SCDG · 1158615
  • Ipratropium bromide Inhalant Product SCDGP · 2663525
  • Ipratropium bromide Nasal Product SCDGP · 2660664

📦 FDA Products & Package NDCs

9 products · 9 package NDCs
9 package NDCs map to RxCUI 1797833 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-0045-44 1 BOTTLE, SPRAY in 1 CARTON (0054-0045-44) / 345 SPRAY in 1... Ipratropium Bromide Hikma Pharmaceuticals USA Inc. 2003-11-05
16714-0526-01 1 BOTTLE, SPRAY in 1 CARTON (16714-526-01) / 345 SPRAY, MET... Ipratropium Bromide NORTHSTAR RX LLC 2022-02-22
24208-0398-30 1 BOTTLE, SPRAY in 1 CARTON (24208-398-30) / 345 SPRAY, MET... Ipratropium bromide Bausch & Lomb Incorporated 2003-03-31
60505-0826-01 1 BOTTLE, SPRAY in 1 CARTON (60505-0826-1) / 345 SPRAY, MET... Ipratropium Bromide Apotex Corp. 2020-05-26
68682-0398-30 1 BOTTLE, SPRAY in 1 CARTON (68682-398-30) / 345 SPRAY, MET... Ipratroprium Bromide Oceanside Pharmaceuticals 2025-06-01
69238-2016-03 1 BOTTLE, SPRAY in 1 CARTON (69238-2016-3) / 345 SPRAY in 1... Ipratropium Bromide Amneal Pharmaceuticals NY LLC 2022-08-18
70748-0336-01 1 BOTTLE, SPRAY in 1 CARTON (70748-336-01) / 345 SPRAY, MET... IPRATROPIUM BROMIDE Lupin Pharmaceuticals, Inc. 2025-07-03
72162-2143-03 1 BOTTLE, SPRAY in 1 CARTON (72162-2143-3) / 345 SPRAY in 1... Ipratropium Bromide Bryant Ranch Prepack 2023-12-07
72888-0149-38 1 BOTTLE in 1 CARTON (72888-149-38) / 345 SPRAY, METERED in... IPRATROPIUM BROMIDE Advagen Pharma Ltd 2025-01-14
Observed labelers: Advagen Pharma Ltd (1) · Amneal Pharmaceuticals NY LLC (1) · Apotex Corp. (1) · Bausch & Lomb Incorporated (1) · Bryant Ranch Prepack (1) · Hikma Pharmaceuticals USA Inc. (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.